Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Not for pregnant or breastfeeding women, minors, or anyone with copper metabolism disorders such as Wilson's disease
Phase 2 trials in diabetes, cognition, and anti-aging applications
Should be preferred: Applied when at least one Phase III randomized controlled trial with prespecified, phenotype-specific primary endpoints demonstrated clinically meaningful benefit, with regulatory approval and no major safety concerns
Oncogene 4(11):1363-74, 1989
US$ 28.47
US$ 29.25
:max_bytes(150000):strip_icc()/VWH-GettyImages-1910940597-18937f51e5ed43d08ea988b0c2a5e163.jpg)
US$ 28.48
/https%3A%2F%2Fopengraph.b-cdn.net%2Fproduction%2Fimages%2F2ed46913-f157-43c3-9418-19fea49af16c.png%3Ftoken%3DUl4O1QAtXTaMUjOfpBooUL-C8jajM-YwYFPrjCtr6ms%26height%3D1080%26width%3D1080%26expires%3D33315971423/og.png)
![Lenco Standard Integrated Tactile Switch Kit w/Pigtail f/Single Actuator Systems [15169-001] Hooks | Size 11/0](https://cdn.shopify.com/s/files/1/1592/4149/products/62757XL.jpg?v=1618274236)